Company news
18.12.09
Lab21 acquires US nanotechnology company and establishes Lab21 Inc. in South Carolina →
26.11.09
Lab21 acquires personalised medicine diagnostic services business →
17.11.09
Lab21 launches new high sensitivity immunodiagnostic system for CMV antibody detection →
15.09.09
Lab21 signs agreement with AstraZeneca to provide genetic testing service in lung cancer →
21.07.09
Lab21 announces publication of syphilis diagnostic patent →
Routine Clinical chemistry and molecular diagnostic services for disease identification, disease predisposition and personalised medicine.
Infectious disease products for diagnostic use and bloodbank screening
Take the FoodCheck test to help you identify if you need to make changes to what you eat.
